These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 23422079)

  • 1. Nonclinical assessment of tumor growth enhancement potential by B2A-coated ceramic granules used in arthodesis.
    Zamora PO; Lin X; Liu Y; Guo H
    Int J Toxicol; 2013; 32(2):146-53. PubMed ID: 23422079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biocompatibility and inflammation profile of B2A-coated granules used in arthrodesis.
    Zamora PO; Liu Y; Guo H; Lin X
    Int J Toxicol; 2013; 32(2):154-61. PubMed ID: 23422080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B2A peptide on ceramic granules enhance posterolateral spinal fusion in rabbits compared with autograft.
    Smucker JD; Bobst JA; Petersen EB; Nepola JV; Fredericks DC
    Spine (Phila Pa 1976); 2008 May; 33(12):1324-9. PubMed ID: 18496344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective pilot study of B2A-coated ceramic granules (Amplex) compared to autograft for ankle and hindfoot arthrodesis.
    Glazebrook M; Younger A; Wing K; Lalonde KA
    Foot Ankle Int; 2013 Aug; 34(8):1055-63. PubMed ID: 23463779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonclinical assessment of carcinogenic risk and tumor growth enhancement potential of prasugrel, a platelet-inhibiting therapeutic agent.
    Buckley LA; Sanbuissho A; Starling JJ; Knadler MP; Iversen PW; Jakubowski JA
    Int J Toxicol; 2012; 31(4):317-25. PubMed ID: 22692976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B2A Polypeptide in Foot and Ankle Fusion.
    Glazebrook M; Young DS
    Foot Ankle Clin; 2016 Dec; 21(4):803-807. PubMed ID: 27871413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling nucleus pulposus regeneration in vitro: mesenchymal stem cells, alginate beads, hypoxia, bone morphogenetic protein-2, and synthetic peptide B2A.
    McCanless JD; Cole JA; Slack SM; Bumgardner JD; Zamora PO; Haggard WO
    Spine (Phila Pa 1976); 2011 Dec; 36(26):2275-85. PubMed ID: 21311397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B2A, a receptor modulator, increases the growth of pluripotent and preosteoblast cells through bone morphogenetic protein receptors.
    Liu Y; Lin X; Takahashi K; Zamora PO
    Growth Factors; 2012 Dec; 30(6):410-7. PubMed ID: 23231667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B2A as a positive BMP receptor modulator.
    Lin X; Guo H; Takahashi K; Liu Y; Zamora PO
    Growth Factors; 2012 Jun; 30(3):149-57. PubMed ID: 22448909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porous ceramic vehicles for rat-marrow-derived (Rattus norvegicus) osteogenic cell delivery: effects of pre-treatment with fibronectin or laminin.
    Dennis JE; Caplan AI
    J Oral Implantol; 1993; 19(2):106-15; discussion 136-7. PubMed ID: 8246297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TMTP1, a novel tumor-homing peptide specifically targeting metastasis.
    Yang W; Luo D; Wang S; Wang R; Chen R; Liu Y; Zhu T; Ma X; Liu R; Xu G; Meng L; Lu Y; Zhou J; Ma D
    Clin Cancer Res; 2008 Sep; 14(17):5494-502. PubMed ID: 18765541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
    Bae DG; Kim TD; Li G; Yoon WH; Chae CB
    Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEDF-derived synthetic peptides exhibit antitumor activity in an orthotopic model of human osteosarcoma.
    Ek ET; Dass CR; Contreras KG; Choong PF
    J Orthop Res; 2007 Dec; 25(12):1671-80. PubMed ID: 17600821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic acid-based polymers as cell carriers for tissue-engineered repair of bone and cartilage.
    Solchaga LA; Dennis JE; Goldberg VM; Caplan AI
    J Orthop Res; 1999 Mar; 17(2):205-13. PubMed ID: 10221837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
    Han L; Huang R; Liu S; Huang S; Jiang C
    Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization of tumor-associated endothelial cell apoptosis by the novel vascular-targeting agent ZD6126 in combination with cisplatin.
    Goto H; Yano S; Matsumori Y; Ogawa H; Blakey DC; Sone S
    Clin Cancer Res; 2004 Nov; 10(22):7671-6. PubMed ID: 15570000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.